RedDress Ltd.

Industry · 7 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Manageme Anal Fistula	N/A	2024-01-20
Recruiting	Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence Dehiscence Wound	N/A	2021-08-01
Terminated	Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wo Wounds	N/A	2021-03-01
Completed	Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs Diabetic Foot, Chronic Ulcer	N/A	2019-12-20
Recruiting	Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers Cutaneous Wounds	—	2019-02-14
Terminated	A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in El Diabetic Foot Ulcer, Pressure Ulcer, Venous Leg Ulcer	N/A	2018-07-11
Completed	Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Neuropathic Diabetic Ulcer - Foot	Phase 2	2014-05-01